Loading ...

Kevin Kaier

Immune Tolerance Network

Assessment Group

kkaier@immunetolerance.org

Work:

415-278-0707

Mobile:

Address:

Immune Tolerance Network

Committees:

,

Studies:

ITN018AI

-

Proleukin and Rapamune in Type 1 Diabetes

ITN021AI

-

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

ITN024ST

-

Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

ITN025AD

-

Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study

ITN027AI

-

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

ITN028AI

-

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

ITN029ST

-

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients

ITN030ST

-

Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

ITN032AD

-

Promoting Tolerance to Peanut in High-Risk Children

ITN033AI

-

High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study

ITN036ST

-

Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection

ITN040CT

-

Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

Bio:

Admin Links

Shortcuts

ITN Documents

Links